x min read

Stocks to Watch: JinkoSolar Holding Co., Ltd. (NYSE:JKS), Alco Stores Inc (NASDAQ:ALCS), MiMedx Group Inc (NASDAQ:MDXG)

Stocks to Watch: JinkoSolar Holding Co., Ltd. (NYSE:JKS), Alco Stores Inc (NASDAQ:ALCS), MiMedx Group Inc (NASDAQ:MDXG)
Written by
Joel Najarian
Published on
October 13, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook

JinkoSolar Holding Co., Ltd. (NYSE:JKS), a solar-module manufacturer, said it has been selected to supply 21.5MW PV modules for the construction of the Searchlight solar project in Nevada, approximately 50 miles south of Las Vegas. The financial value of the contract wasn't disclosed. A total of 70,525 high-efficiency JinkoSolar modules will be used in the construction of this project, which will generate approximately 45,000MWh of clean energy annually for NV Energy customers once it is connected to the grid by the end of 2014, the company said. The project is being developed by D.E. Shaw Renewable Investments and Bright Plain Renewable Energy, both privately held. Shares of JinkoSolar Holding Co., Ltd. (NYSE:JKS) shares are trading within a 52-week range of $19.06 to $37.98.Alco Stores Inc (NASDAQ:ALCS) filed for Chapter 11 bankruptcy on Sunday. ALCS plans to liquidate or sell the 113-year-old retail operation. In court papers, ALCS blamed the effects of the "lingering economic slowdown" on its customers, many of whom are living on fixed or low incomes in rural areas. While it has positioned its stores to avoid head-to-head competition with larger discount chains, Alco Stores Inc (NASDAQ:ALCS) said it couldn't escape the effects of economic distress in the U.S. While it seeks bankruptcy-court approval to move ahead with the liquidation, ALCS will also be pursuing a going-concern sale that would preserve operations at some or all of the stores. Potential buyers have been approached, ALCS Chief Executive Stanley Latacha said in a court filing.MiMedx Group Inc (NASDAQ:MDXG) the regenerative-medicine company reported higher-than-expected Q3 revenue while boosting its outlook for 2014 revenue above the Street view and forecasting Q4 and 2015 revenue above analysts' expectations. MiMedx Group Inc (NASDAQ:MDXG) is trading between a 52-week range of $4.41 to $8.80. The company posted Q3 revenue of $33.5 million, more than double the $16.1 million it posted in the year-earlier period and above its prior guidance of $30 million to $32 million. The result was also above analysts' mean estimate of $31 million, according to Capital IQ.MDXG also said it recorded its first-ever operating profit in Q3, but didn't disclose the size of the profit. Also Monday, MDXG forecast Q4 revenue of $37.3 million to $38.3 million and boosted its 2014 revenue guidance to $116 million to $117 million from its late-July guidance of $110 million to $115 million, which had been up from a previous forecast. Analysts recently were looking for $36.4 million and $112.5 million, respectively. It sees 2015 revenue of $175 million to $185 million, above analysts' mean estimate of $161.3 million, and said it expects 2015 operating profit margin to exceed 15%.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.